nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetazolamide—CA9—cervical cancer	0.819	1	CbGaD
Acetazolamide—CA3—Reversible hydration of carbon dioxide—CA9—cervical cancer	0.0138	0.155	CbGpPWpGaD
Acetazolamide—CA14—Reversible hydration of carbon dioxide—CA9—cervical cancer	0.00891	0.0996	CbGpPWpGaD
Acetazolamide—CA5A—Reversible hydration of carbon dioxide—CA9—cervical cancer	0.00868	0.0971	CbGpPWpGaD
Acetazolamide—CA6—Reversible hydration of carbon dioxide—CA9—cervical cancer	0.00868	0.0971	CbGpPWpGaD
Acetazolamide—AQP1—exocrine gland—cervical cancer	0.00817	0.0965	CbGeAlD
Acetazolamide—CA7—Reversible hydration of carbon dioxide—CA9—cervical cancer	0.0081	0.0906	CbGpPWpGaD
Acetazolamide—CA5B—Reversible hydration of carbon dioxide—CA9—cervical cancer	0.0081	0.0906	CbGpPWpGaD
Acetazolamide—CA12—Reversible hydration of carbon dioxide—CA9—cervical cancer	0.00751	0.084	CbGpPWpGaD
Acetazolamide—Methazolamide—CA9—cervical cancer	0.00719	1	CrCbGaD
Acetazolamide—CA6—exocrine gland—cervical cancer	0.00633	0.0747	CbGeAlD
Acetazolamide—CA4—Reversible hydration of carbon dioxide—CA9—cervical cancer	0.00599	0.067	CbGpPWpGaD
Acetazolamide—CA2—Reversible hydration of carbon dioxide—CA9—cervical cancer	0.00574	0.0642	CbGpPWpGaD
Acetazolamide—CA1—Reversible hydration of carbon dioxide—CA9—cervical cancer	0.0055	0.0615	CbGpPWpGaD
Acetazolamide—AQP1—epithelium—cervical cancer	0.00355	0.042	CbGeAlD
Acetazolamide—AQP1—uterine cervix—cervical cancer	0.00352	0.0416	CbGeAlD
Acetazolamide—AQP1—decidua—cervical cancer	0.00336	0.0397	CbGeAlD
Acetazolamide—AQP1—renal system—cervical cancer	0.0033	0.0389	CbGeAlD
Acetazolamide—AQP1—endometrium—cervical cancer	0.00319	0.0376	CbGeAlD
Acetazolamide—CA5A—female reproductive system—cervical cancer	0.00317	0.0375	CbGeAlD
Acetazolamide—AQP1—mammalian vulva—cervical cancer	0.00308	0.0364	CbGeAlD
Acetazolamide—AQP1—uterus—cervical cancer	0.00294	0.0347	CbGeAlD
Acetazolamide—AQP1—female reproductive system—cervical cancer	0.00264	0.0312	CbGeAlD
Acetazolamide—CA7—renal system—cervical cancer	0.00264	0.0311	CbGeAlD
Acetazolamide—CA3—uterine cervix—cervical cancer	0.00258	0.0305	CbGeAlD
Acetazolamide—AQP1—female gonad—cervical cancer	0.0024	0.0284	CbGeAlD
Acetazolamide—AQP1—vagina—cervical cancer	0.00239	0.0282	CbGeAlD
Acetazolamide—CA2—exocrine gland—cervical cancer	0.00218	0.0257	CbGeAlD
Acetazolamide—CA3—uterus—cervical cancer	0.00215	0.0254	CbGeAlD
Acetazolamide—CA1—C-MYB transcription factor network—PIAS3—cervical cancer	0.00188	0.021	CbGpPWpGaD
Acetazolamide—CA9—female reproductive system—cervical cancer	0.00185	0.0219	CbGeAlD
Acetazolamide—CA3—vagina—cervical cancer	0.00175	0.0207	CbGeAlD
Acetazolamide—CA12—renal system—cervical cancer	0.00171	0.0202	CbGeAlD
Acetazolamide—AQP1—lymph node—cervical cancer	0.00154	0.0182	CbGeAlD
Acetazolamide—CA5B—mammalian vulva—cervical cancer	0.00144	0.017	CbGeAlD
Acetazolamide—CA12—female reproductive system—cervical cancer	0.00137	0.0162	CbGeAlD
Acetazolamide—CA1—renal system—cervical cancer	0.00136	0.016	CbGeAlD
Acetazolamide—CA5B—female reproductive system—cervical cancer	0.00123	0.0145	CbGeAlD
Acetazolamide—CA3—lymph node—cervical cancer	0.00113	0.0134	CbGeAlD
Acetazolamide—CA5B—vagina—cervical cancer	0.00111	0.0131	CbGeAlD
Acetazolamide—CA1—female reproductive system—cervical cancer	0.00109	0.0128	CbGeAlD
Acetazolamide—CA4—renal system—cervical cancer	0.00106	0.0125	CbGeAlD
Acetazolamide—CA2—epithelium—cervical cancer	0.000948	0.0112	CbGeAlD
Acetazolamide—CA2—decidua—cervical cancer	0.000895	0.0106	CbGeAlD
Acetazolamide—CA2—renal system—cervical cancer	0.000879	0.0104	CbGeAlD
Acetazolamide—CA4—female reproductive system—cervical cancer	0.000849	0.01	CbGeAlD
Acetazolamide—CA2—mammalian vulva—cervical cancer	0.000822	0.00971	CbGeAlD
Acetazolamide—CA4—female gonad—cervical cancer	0.000773	0.00912	CbGeAlD
Acetazolamide—CA5B—lymph node—cervical cancer	0.00072	0.0085	CbGeAlD
Acetazolamide—CA2—female reproductive system—cervical cancer	0.000704	0.00831	CbGeAlD
Acetazolamide—CA2—female gonad—cervical cancer	0.000641	0.00757	CbGeAlD
Acetazolamide—CA2—vagina—cervical cancer	0.000637	0.00752	CbGeAlD
Acetazolamide—CA1—lymph node—cervical cancer	0.000635	0.0075	CbGeAlD
Acetazolamide—AQP1—Spinal Cord Injury—CASP3—cervical cancer	0.000615	0.00688	CbGpPWpGaD
Acetazolamide—CYP3A4—renal system—cervical cancer	0.000567	0.0067	CbGeAlD
Acetazolamide—CA1—C-MYB transcription factor network—HES1—cervical cancer	0.000536	0.00599	CbGpPWpGaD
Acetazolamide—CA9—HIF-1-alpha transcription factor network—TERT—cervical cancer	0.0005	0.0056	CbGpPWpGaD
Acetazolamide—CA4—lymph node—cervical cancer	0.000497	0.00587	CbGeAlD
Acetazolamide—AQP1—Spinal Cord Injury—EGFR—cervical cancer	0.00047	0.00526	CbGpPWpGaD
Acetazolamide—CYP3A4—female reproductive system—cervical cancer	0.000454	0.00536	CbGeAlD
Acetazolamide—CA2—lymph node—cervical cancer	0.000412	0.00486	CbGeAlD
Acetazolamide—AQP1—Spinal Cord Injury—TP53—cervical cancer	0.000395	0.00441	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—CA9—cervical cancer	0.000324	0.00362	CbGpPWpGaD
Acetazolamide—CA1—C-MYB transcription factor network—CD4—cervical cancer	0.000302	0.00338	CbGpPWpGaD
Acetazolamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000301	0.00337	CbGpPWpGaD
Acetazolamide—CYP3A4—Tryptophan metabolism—UBE3A—cervical cancer	0.00029	0.00324	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—CA9—cervical cancer	0.000281	0.00314	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—CA9—cervical cancer	0.000181	0.00202	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—CA9—cervical cancer	0.000176	0.00197	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—CA9—cervical cancer	0.000176	0.00197	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—CA9—cervical cancer	0.000165	0.00184	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—CA9—cervical cancer	0.000165	0.00184	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—CA9—cervical cancer	0.000153	0.00171	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—MTHFR—cervical cancer	0.000131	0.00147	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CA9—cervical cancer	0.000122	0.00136	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CA9—cervical cancer	0.000117	0.0013	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—MTHFR—cervical cancer	0.000114	0.00127	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CA9—cervical cancer	0.000112	0.00125	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—MTOR—cervical cancer	0.000107	0.00119	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—STAT3—cervical cancer	8.24e-05	0.000921	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—MTHFR—cervical cancer	7.34e-05	0.000821	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—MTHFR—cervical cancer	7.16e-05	0.000801	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—MTHFR—cervical cancer	7.16e-05	0.000801	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—MTHFR—cervical cancer	6.68e-05	0.000747	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—MTHFR—cervical cancer	6.68e-05	0.000747	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—TP53—cervical cancer	6.29e-05	0.000703	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—MTHFR—cervical cancer	6.19e-05	0.000692	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—MTHFR—cervical cancer	4.94e-05	0.000552	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—MTHFR—cervical cancer	4.73e-05	0.000529	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—MTHFR—cervical cancer	4.54e-05	0.000508	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—MTHFR—cervical cancer	3.99e-05	0.000446	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CA9—cervical cancer	1.65e-05	0.000185	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—MTHFR—cervical cancer	6.72e-06	7.51e-05	CbGpPWpGaD
